日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical presentation and outcomes of medullary thyroid cancer in two European countries: impact of diagnostic strategies

欧洲两个国家甲状腺髓样癌的临床表现和预后:诊断策略的影响

Ceruti, Daniele; Bonenkamp, Han J; Colombo, Carla; Gotthardt, Martin; De Leo, Simone; van Herwaarden, Antonius E; Ottevanger, Petronella B; Netea-Maier, Romana T; Fugazzola, Laura

The effect of neoadjuvant radiotherapy on immune cell infiltrates in myxofibrosarcoma

新辅助放疗对粘液纤维肉瘤中免疫细胞浸润的影响

Nederkoorn, M J L; Flucke, U E; Hillebrandt-Roeffen, M H S; Gorris, M A J; van Ravensteijn, S G; Verrijp, K; Braam, P M; Bonenkamp, J J; Dierselhuis, E F; Ruijter, E; Wetzels-van der Velden, C; Kusters-Vandevelde, H V N; Huysentruyt, C J R; Grefte, J M M; de Wilt, J H W; Desar, I M E; Versleijen-Jonkers, Y M H

The role of radiotherapy in MPNST and the impact of NF1 status on outcomes: Insights from a multicenter cohort study

放射治疗在恶性周围神经鞘瘤中的作用以及NF1状态对预后的影响:一项多中心队列研究的启示

Jansma, Christianne Y M N; Grünhagen, Dirk J; Flucke, Uta E; Slooff, Willem-Bart M; van Dalen, Thijs; Been, Lukas B; Bonenkamp, Han J; Anten, Monique H M E; Broen, Martinus P G; Bemelmans, Marc H A; Bramer, Jos A M; Schaap, Gerard R; Kievit, Arthur J; van Houdt, Winan J; van der Hage, Jos; van de Sande, Michiel A J; Pendleton, Courtney; Spinner, Robert J; Coert, J Henk; Verhoef, Cornelis; Taal, Walter; Martin, Enrico

Cemiplimab in Locally Advanced or Metastatic Secondary Angiosarcomas (CEMangio): A Phase II Clinical Trial and Biomarker Analyses

Cemiplimab治疗局部晚期或转移性继发性血管肉瘤(CEMangio):一项II期临床试验和生物标志物分析

Stefan G van Ravensteijn ,Jacco J de Haan ,Hans Gelderblom ,Maikel J L Nederkoorn ,Melissa H S Hillebrandt-Roeffen ,Mark A J Gorris ,Tessa J J de Bitter ,Annemarie Boleij ,Alem Gusinac ,Thomas H A Ederveen ,Uta E Flucke ,Johannes J Bonenkamp ,Frank M Speetjens ,Suzanne E J Kaal ,Minke Smits ,Kalijn F Bol ,Carla M L van Herpen ,Yvonne M H Versleijen-Jonkers ,Ingrid M E Desar

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis

BRAF/MEK 辅助治疗与抗 PD-1 治疗 BRAF 突变型黑色素瘤的疗效比较:倾向评分匹配生存分析

Bloem, M; de Meza, M M; van den Eertwegh, A J M; Aarts, M J B; van den Berkmortel, F W P J; Blank, C U; Blokx, W A M; Boers-Sonderen, M J; Bonenkamp, J J; Boreel, C D M; de Groot, J W B; Haanen, J B A G; Hospers, G A P; Kapiteijn, E; van Not, O J; Piersma, D; Rikhof, B; Stevense-den Boer, A M; van der Veldt, A A M; Vreugdenhil, G; Suijkerbuijk, K P M; Wouters, M W J M

Induction of trained immunity in myeloid cells and their progenitors from thyroid cancer patients

诱导甲状腺癌患者髓系细胞及其祖细胞产生训练免疫

van Houten, Pepijn; Changoer, Prashant; van Emst, Liesbeth; Bonenkamp, Han J; de Wilt, Johannes H W; Hobo, Willemijn; Bremmers, Manita E J; Roeven, Mieke W H; Walraven, Janneke E W; Ottevanger, Petronella B; Mulder, Willem J M; Netea, Mihai G; Jaeger, Martin; Netea-Maier, Romana T

OR17-04 Reprogramming myeloid bone marrow progenitors in non-medullary thyroid cancer using trained immunity

OR17-04 利用训练免疫对非髓样甲状腺癌中的髓系骨髓祖细胞进行重编程

Nelson, G S; Amin, M A; Saoud, M F; Teesdale, C; van Houten, Pepijn; Jaeger, Martin; Changoer, Prashant; van Emst, Liesbeth; Mulder, Willem; van Engen-van Grunsven, Ilse C H; Bremmers, Manita; Bonenkamp, Han J; de Wilt, Johannes H W; Hobo, Willemijn; Netea, Mihai G; Netea-Maier, Romana Teodora

Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST

突变谱对胃肠道间质瘤新辅助治疗疗效的影响

Mohammadi, Mahmoud; Roets, Evelyne; Bleckman, Roos F; Oosten, Astrid W; Grunhagen, Dirk; Desar, Ingrid M E; Bonenkamp, Han; Reyners, Anna K L; van Etten, Boudewijn; Hartgrink, Henk; Fiocco, Marta; Schrage, Yvonne; Steeghs, Neeltje; Gelderblom, Hans

Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies

欧洲两家转诊中心的分化型甲状腺癌:不同诊断和治疗策略的影响

Ceruti, Daniele; Ottevanger, Petronella B; De Leo, Simone; Bonenkamp, Han J; Colombo, Carla; Gotthardt, Martin; Fugazzola, Laura; Netea-Maier, Romana T

Evaluating the effectiveness of a risk prediction model (PERSARC) on improving treatment decisions quality for patients with soft-tissue sarcomas: the VALUE-PERSARC study

评估风险预测模型(PERSARC)在改善软组织肉瘤患者治疗决策质量方面的有效性:VALUE-PERSARC 研究

Kruiswijk, Anouk A; de Mheen, Perla J Marang-van; Vlug, Lisa A E; Engelhardt, Ellen G; Fiocco, Marta; Haas, Rick L; Schrage, Yvonne M; Verhoef, Cornelis; Bemelmans, Marc H A; van Ginkel, Robert J; Bonenkamp, Johannes J; Witkamp, Arjen J; van de Sande, Michiel A J; van Bodegom-Vos, Leti